Yahoo
NasdaqCM - Nasdaq Real Time Price USD

NRx Pharmaceuticals, Inc. (NRXP)

2.2700 -0.3900 (-14.66%)
At close: October 30 at 4:00:01 PM EDT
2.2100 -0.0600 (-2.64%)
After hours: October 30 at 7:59:28 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,394
1,225
0
0
0
Cost of Revenue
1,811
505
0
--
--
Gross Profit
1,583
720
0
--
--
Operating Expense
21,583
16,944
18,502
27,587
44,335
Operating Income
-20,000
-16,224
-18,502
-27,587
-44,335
Net Non Operating Interest Income Expense
-1,124
-659
-186
374
249
Other Income Expense
-2,356
-11,739
-6,438
-2,937
4,332
Pretax Income
-23,480
-28,622
-25,126
-30,150
-39,754
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-23,480
-28,622
-25,126
-30,159
-39,754
Diluted NI Available to Com Stockholders
-23,480
-28,622
-25,126
-30,159
-39,754
Basic EPS
-0.51
-1.34
-2.36
-3.98
-6.10
Diluted EPS
-0.51
-1.34
-2.36
-3.98
-6.10
Basic Average Shares
30,280.2320
21,401.6830
10,644.4610
7,576.1760
6,576.6780
Diluted Average Shares
30,280.2320
21,401.6830
10,644.4610
7,576.1760
6,576.6780
Total Operating Income as Reported
-19,897
-16,224
-18,502
-27,837
-44,335
Total Expenses
23,394
17,449
18,502
27,587
44,335
Net Income from Continuing & Discontinued Operation
-23,480
-28,622
-25,126
-30,150
-39,754
Normalized Income
-21,298
-27,788
-23,469
-29,920
-44,591
Interest Income
17
12
44
494
249
Interest Expense
1,141
671
230
120
0
Net Interest Income
-1,124
-659
-186
374
249
EBIT
-22,339
-27,951
-24,896
-30,030
-39,754
EBITDA
-21,858
-27,808
-24,891
-30,025
-39,750
Reconciled Cost of Revenue
1,534
432
0
--
--
Reconciled Depreciation
481
143
5
5
4
Net Income from Continuing Operation Net Minority Interest
-23,480
-28,622
-25,126
-30,150
-39,754
Total Unusual Items Excluding Goodwill
-2,182
-834
-1,657
-230
4,837
Total Unusual Items
-2,182
-834
-1,657
-230
4,837
Normalized EBITDA
-19,676
-26,974
-23,234
-29,795
-44,587
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/4/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: